Diabetic nephropathy: Diagnosis and treatment

Research output: Contribution to journalReview ArticleOtherpeer-review

Abstract

Nephropathy remains a major cause of morbidity and a key determinant of mortality in patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers that in addition to albuminuria and glomerular filtration rate assist in the prediction and monitoring of renal disease in diabetes mellitus. Current strategies to treat this condition focus on intensification of glycaemic control and excellent control of blood pressure using regimens based on blockade of the renin-angiotensin system. Other approaches to control blood pressure and afford renoprotection are under active clinical investigation, including renal denervation and endothelin receptor antagonism. With increasing understanding of the underlying pathophysiological processes implicated in diabetic nephropathy, new specific renoprotective treatment strategies are anticipated to become available over the next few years.

Original languageEnglish
Pages (from-to)713-723
Number of pages11
JournalNature Reviews Endocrinology
Volume9
Issue number12
DOIs
Publication statusPublished - Dec 2013
Externally publishedYes

Cite this

@article{fb5ae6e2201f467a862d6a7b2c8cb925,
title = "Diabetic nephropathy: Diagnosis and treatment",
abstract = "Nephropathy remains a major cause of morbidity and a key determinant of mortality in patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers that in addition to albuminuria and glomerular filtration rate assist in the prediction and monitoring of renal disease in diabetes mellitus. Current strategies to treat this condition focus on intensification of glycaemic control and excellent control of blood pressure using regimens based on blockade of the renin-angiotensin system. Other approaches to control blood pressure and afford renoprotection are under active clinical investigation, including renal denervation and endothelin receptor antagonism. With increasing understanding of the underlying pathophysiological processes implicated in diabetic nephropathy, new specific renoprotective treatment strategies are anticipated to become available over the next few years.",
author = "Daniel Fineberg and Jandeleit-Dahm, {Karin A. M.} and Cooper, {Mark E.}",
year = "2013",
month = "12",
doi = "10.1038/nrendo.2013.184",
language = "English",
volume = "9",
pages = "713--723",
journal = "Nature Reviews Endocrinology",
issn = "1759-5029",
publisher = "Nature Publishing Group",
number = "12",

}

Diabetic nephropathy : Diagnosis and treatment. / Fineberg, Daniel; Jandeleit-Dahm, Karin A. M.; Cooper, Mark E.

In: Nature Reviews Endocrinology, Vol. 9, No. 12, 12.2013, p. 713-723.

Research output: Contribution to journalReview ArticleOtherpeer-review

TY - JOUR

T1 - Diabetic nephropathy

T2 - Diagnosis and treatment

AU - Fineberg, Daniel

AU - Jandeleit-Dahm, Karin A. M.

AU - Cooper, Mark E.

PY - 2013/12

Y1 - 2013/12

N2 - Nephropathy remains a major cause of morbidity and a key determinant of mortality in patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers that in addition to albuminuria and glomerular filtration rate assist in the prediction and monitoring of renal disease in diabetes mellitus. Current strategies to treat this condition focus on intensification of glycaemic control and excellent control of blood pressure using regimens based on blockade of the renin-angiotensin system. Other approaches to control blood pressure and afford renoprotection are under active clinical investigation, including renal denervation and endothelin receptor antagonism. With increasing understanding of the underlying pathophysiological processes implicated in diabetic nephropathy, new specific renoprotective treatment strategies are anticipated to become available over the next few years.

AB - Nephropathy remains a major cause of morbidity and a key determinant of mortality in patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers that in addition to albuminuria and glomerular filtration rate assist in the prediction and monitoring of renal disease in diabetes mellitus. Current strategies to treat this condition focus on intensification of glycaemic control and excellent control of blood pressure using regimens based on blockade of the renin-angiotensin system. Other approaches to control blood pressure and afford renoprotection are under active clinical investigation, including renal denervation and endothelin receptor antagonism. With increasing understanding of the underlying pathophysiological processes implicated in diabetic nephropathy, new specific renoprotective treatment strategies are anticipated to become available over the next few years.

UR - http://www.scopus.com/inward/record.url?scp=84888199970&partnerID=8YFLogxK

U2 - 10.1038/nrendo.2013.184

DO - 10.1038/nrendo.2013.184

M3 - Review Article

VL - 9

SP - 713

EP - 723

JO - Nature Reviews Endocrinology

JF - Nature Reviews Endocrinology

SN - 1759-5029

IS - 12

ER -